Treatment Patterns And Clinical Outcomes In Pazopanib Compared With Sunitinib As First-Line Therapy For Patients With Advanced/Metastatic Renal Cell Carcinoma In A Community Oncology Setting In The United States
Abstract
Authors
B Hirsch X Jiao T Wilson SR Ghate M Hackshaw JR Perez N Vogelzang